Find the latest oncology news for your sub-specialty area
Just like people, some T cells have excellent memories. These subtypes known as memory T…
Scientists have identified 80 molecular weaknesses in prostate cancer that could be targeted by drugs…
According to new research conducted in mice by Whitehead Institute scientists, surgery in breast cancer…
“You don’t exactly want your tumour to take home and stick on your mantelpiece -…
Children with non-chromosomal birth defects such as congenital heart disease had a significantly higher risk…
A one-year course of 18 doses of pembrolizumab significantly reduced the risk of recurrence for…
BLU-667, a next-generation inhibitor that selectively targets the oncogenic receptor tyrosine kinase RET, was well…
The final results of the palliative cohort of the SORAMIC study in patients with unresectable,…
Among patients with newly diagnosed advanced non-small cell lung cancer (NSCLC) with high tumour mutational…
Among patients with inoperable, advanced, or metastatic ALK-positive inflammatory myofibroblastic tumour, 50 percent were confirmed…